US Med-Equip (PRIVATE.USMEDEQ)

Overall impact
C (43)

Commentary

US Med-Equip is an average overall performer. With a 'C' rating of 42.5 for overall impact (28th percentile compared to all companies), US Med-Equip ranks 197th out of 200 industry peers, behind Restoration Robotics, Corindus Vascular Robotics, Modular Medical and 193 others, and ahead of Carestream Health, Resonetics, and Tyber Medical. On top material causes for US Med-Equip's industry (Health Care Equipment & Supplies), US Med-Equip performs well in Child and Maternal Health (95.2 score), Technology Innovation (94.7), Technology Innovation (94.7) and 12 other causes where it received an 'A' score and performs poorly in Humane Treatment of Animals (1.3 score), Humane Treatment of Animals (1.3), Sustainable Use of Natural Resources (28.5) and 30 other causes where it received a 'D' or 'F' score.
Impact
Cause PRIVATE.USMEDEQ
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Employees
700
Sector
Health Care
Industry
Health Care Equipment & Supplies
Sub-industry
Health Care Equipment
SASB industry
Medical Equipment & Supplies
Share classes
PRIVATE.USMEDEQ
Description
US Med-Equip (USME) is a Houston-based medical equipment and supplies company that partners with hospitals nationwide to provide, rent, sell, maintain and manage durable/movable medical equipment — including beds and therapeutic surfaces — and offers rapid delivery commitments.
Material causes
Ethos considers the following causes material for US Med-Equip, based on its industry sub-industry Health Care Equipment. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.